Cargando…

QT prolongation in the STREAM Stage 1 Trial

BACKGROUND : STREAM (Standardized Treatment Regimen of Anti-TB Drugs for Patients with MDR-TB) Stage 1 demonstrated non-inferior efficacy of a shortened regimen (the Short regimen) for rifampicinresistant TB (RR-TB) compared to the contemporaneous WHO-recommended regimen. This regimen included moxif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hughes, G., Bern, H., Chiang, C-Y., Goodall, R. L., Nunn, A. J., Rusen, I. D., Meredith, S. K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Union 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982645/ https://www.ncbi.nlm.nih.gov/pubmed/35351238 http://dx.doi.org/10.5588/ijtld.21.0403

Ejemplares similares

Investigation of the efficacy of the short regimen for rifampicin-resistant TB from the STREAM trial
por: Phillips, P. P. J., et al.
Publicado: (2020)

Keeping up with the guidelines: design changes to the STREAM stage 2 randomised controlled non-inferiority trial for rifampicin-resistant tuberculosis
por: Goodall, Ruth L., et al.
Publicado: (2022)

Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial
por: Goodall, Ruth L, et al.
Publicado: (2022)

Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial
por: Nunn, Andrew J, et al.
Publicado: (2014)

QT prolongation with methadone
por: Dhamija, Radhika, et al.
Publicado: (2008)

Antipsychotic Medication and QT Prolongation
por: Chohan, Paramdip Singh, et al.
Publicado: (2015)

QT Prolongation in Cancer Patients
por: Kim, Peter, et al.
Publicado: (2021)

QT prolongation is associated with increased mortality in end stage liver disease
por: Kim, Sun Moon, et al.
Publicado: (2017)

Economic evaluation of short treatment for multidrug-resistant tuberculosis, Ethiopia and South Africa: the STREAM trial
por: Madan, Jason J, et al.
Publicado: (2020)

Beyond a prolonged QT interval
por: Bitar, Zouheir Ibrahim, et al.
Publicado: (2013)

QT Prolongation due to Graves' Disease
por: Kulairi, Zain, et al.
Publicado: (2017)

Hydroxychloroquine-associated QT interval prolongation
Publicado: (2020)

Trousseau’s sign and QT prolongation in hypocalcaemia
por: Schnur, Jack, et al.
Publicado: (2021)

An antiarrhythmic approach to hydroxychloroquine-induced QT prolongation
por: Yetkin, E., et al.
Publicado: (2020)

Energy Drinks: Another Cause of QT Prolongation?
por: Winniford, Michael D.
Publicado: (2019)

The predictive ability of the QT response in supine-standing test for drug induced QT prolongation
por: Hochstadt, A, et al.
Publicado: (2023)

Implementation challenges and lessons learned from the STREAM clinical trial—a survey of trial sites
por: Patel, Leena N., et al.
Publicado: (2023)

Prevalence and risk factors for prolonged QT interval and QT dispersion in patients with type 2 diabetes
por: Ninkovic, Vladan M., et al.
Publicado: (2016)

Effect of QT interval-prolonging drugs taken in pregnancy on the neonatal QT interval
por: Michel, Holger, et al.
Publicado: (2023)

How to Diagnose and Manage QT Prolongation in Cancer Patients
por: Kim, Peter Y., et al.
Publicado: (2021)

Use of QT Prolonging Medications by Hemodialysis Patients and Individuals Without End‐Stage Kidney Disease
por: Assimon, Magdalene M., et al.
Publicado: (2020)

Effect of Intensive Glycemic and Blood Pressure Control on QT Prolongation in Diabetes: The ACCORD Trial
por: Singleton, Matthew J., et al.
Publicado: (2020)

QT Interval Prolongation with One or More QT-Prolonging Agents Used as Part of a Multidrug Regimen for Rifampicin-Resistant Tuberculosis Treatment: Findings from Two Pediatric Studies
por: Ali, Ali Mohamed, et al.
Publicado: (2023)

DOTHIEPIN, QT PROLONGATION AND TORSADES DE POINTES
por: Andrade, Chittaranjan, et al.
Publicado: (1999)

A Case of QT Prolongation Associated with Panhypopituitarism
por: Arpaci, Dilek, et al.
Publicado: (2013)

Multifactorial QT Interval Prolongation and Takotsubo Cardiomyopathy
por: Gysel, Michael, et al.
Publicado: (2014)

QT interval prolongation with hydroxychloroquine plus azithromycin
Publicado: (2020)

Hydroxychloroquine: risk of QT prolongation and drug interactions
Publicado: (2020)

Azithromycin: QT interval prolongation: case report
Publicado: (2021)

Chloroquine: QT interval prolongation: case report
Publicado: (2021)

Multiple drugs: QT prolongation: case report
Publicado: (2022)

Prolonged QT Interval in Cirrhosis: Twisting Time?
por: Lee, William, et al.
Publicado: (2022)

Trazodone Overdose Manifesting as Hypotension and QT Prolongation
por: Mohan, Gaurav, et al.
Publicado: (2023)

Magnesium Supplementation Shortens Hemodialysis-Associated Prolonged QT
por: Umapathi, Krishna Kishore, et al.
Publicado: (2020)

QT prolongation in HIV-positive patients: Review article
por: Liu, Jing, et al.
Publicado: (2019)

Pharmacogenetics of Drug-Induced QT Interval Prolongation: An Update
por: Niemeijer, Maartje N., et al.
Publicado: (2015)

QT Prolongation: Psychotropic medication versus illicit drugs
por: Florian, A., et al.
Publicado: (2022)

Concentration‐QT modelling shows no evidence of clinically significant QT interval prolongation with capivasertib at expected therapeutic concentrations
por: Voronova, Veronika, et al.
Publicado: (2021)

Comment on “The Incidence of QT Prolongation and Torsades des Pointes in Patients Receiving Droperidol in an Urban Emergency Department”
por: DiSalvo, Philip C., et al.
Publicado: (2021)

Prolonged Corrected QT Interval in Patients with Myotonic Dystrophy Type 1
por: Park, Kang Min, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_e8pi5d0pa7oj7bsjdo9vbdin01